Gradient Investments LLC Ionis Pharmaceuticals Inc Transaction History

Gradient Investments LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 26, 2022	SELL	$29.88 - $37.04 $5,557 - $6,889	-186 Reduced 67.15%	91 $3,000
Q4 2021 Jan 12, 2022	BUY	$25.61 - $35.1 $4,763 - $6,528	186 Added 204.4%	277 $8,000
Q2 2020 Jul 10, 2020	SELL	$46.85 - $61.05 $843 - $1,098	-18 Reduced 16.51%	91 $5,000
Q1 2020 Apr 07, 2020	BUY	$41.6 - $63.4 $748 - $1,141	18 Added 19.78%	109 $5,000
Q4 2019 Jan 15, 2020	SELL	$53.85 - $65.27 $1,292 - $1,566	-24 Reduced 20.87%	91 $5,000
Q3 2019 Oct 10, 2019	BUY	$59.06 - $72.15 $6,791 - $8,297	115 New	115 $7,000
Q2 2018 Aug 09, 2018	SELL	$40.53 - $50.7 $10,132 - $12,675	-250 Closed	0 $0
Q4 2017 Feb 07, 2018	BUY	$50.3 - $64.39 $12,575 - $16,097	250	250 $13,000

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Gradient Investments LLC with notifications on news.